See the Full Picture.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Immigration and Customs Enforcement
Artificial Intelligence
Donald Trump
Senate
Social Media
World Cup
Immigration
Work
Taxes
Cryptocurrency
Trade
European Union
Published • loading... • Updated

Alzheimer's research suffers 'devastating blow' after new drug rejected by NHS

Summary by Stv
The Scottish Medicines Consortium says there isn't enough evidence to prove how well donanemab treats dementia.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
StvStv

Alzheimer's research suffers 'devastating blow' after new drug rejected by NHS

The Scottish Medicines Consortium says there isn't enough evidence to prove how well donanemab treats dementia.

·Scotland, United Kingdom
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Stv broke the news in Scotland, United Kingdom on Monday, June 9, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Alzheimer's Disease

Alzheimer's Disease

Dementia

Dementia

NHS

NHS

Scotland, United Kingdom

Scotland, United Kingdom

News
For You
SearchBlindspotLocal